Texans most likely to travel out of state for abortions last year: Study
That is a slight drop from the more than 170,000 people who traveled out of state for the procedure in 2023, according to the report from the Guttmacher Institute, a reproductive health and rights group.
More than 28,000 Texans crossed state lines in 2024 to receive abortion care, with many traveling to states as far away as New York, Washington, Maryland and Michigan. These Lone Star State residents traveled to a total of 14 states to receive the care last year, with most visiting nearby states like New Mexico, Colorado and Kansas, according to the report.
Abortion has been almost entirely banned in Texas since 2021. Now, the procedure is only permitted to save the life of a pregnant patient, with violators subject to life in prison, loss of licensure, or fines of up to $100,000.
The law is confusing and vague, health care workers say, causing some to forgo providing life-saving abortions.
The report does not provide details on the logistical, financial or social obstacles the people faced while traveling to receive abortions.
'In addition to travel costs, driving or flying across state lines often requires taking time off work, navigating complex logistics and arranging childcare, not to mention paying for the abortion itself,' Isaac Maddow-Zimet, Guttmacher Institute data scientist and lead author of the study, wrote.
The study was released on the third anniversary of the Supreme Court's Dobbs v. Jackson Women's Health Organization decision, which overturned Roe v, Wade and federal protections for abortion access.
Since then, at least 12 states have almost entirely banned abortion, and another 10 have severely restricted access to it, according to an analysis from the healthcare policy nonprofit KFF.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
9 hours ago
- Axios
Abortion pill fight reaches pharmacy board rooms
A year after the Supreme Court preserved abortion pill access, the fight over dispensing mifepristone is shifting from courtrooms to boardrooms as anti-abortion forces press pharmacy chains not to sell the drugs. The big picture: Costco last week said it won't stock mifepristone at its more than 500 pharmacies. Conservative groups are pushing other pharmacies — including Walgreens and CVS, which offer the pills in states where abortion is legal — to follow suit. "We can effectuate real change by talking to these companies and engaging with them," said Michael Ross, legal counsel for Alliance Defending Freedom's corporate engagement team. "Hopefully Costco will be a trendsetter." But those efforts are making retail pharmacies a new ground zero in the fight over abortion access. Costco got swift criticism from one of its home-state senators, Washington Democrat Patty Murray, for accommodating "far-right extremists" she said were whipsawing the availability of basic care. Between the lines: Pharmacy chains were destined to be involved after the Food and Drug Administration in 2023 allowed retailers to apply for certification to dispense mifepristone, which is part of a two-step protocol used to medically end a pregnancy through 10 weeks. The drug, which FDA first approved in 2000, has traditionally been dispensed at doctors' offices, hospitals or health clinics. But as states across the country restrict abortion, mifepristone prescribing via telehealth has significantly increased. State of play: Costco says it won't pursue approval to dispense mifepristone because demand for the drug is low. The company's understanding is that patients generally get the drug directly from their medical providers, it said in an email. But the decision, which reportedly came after more than a year of deliberations, is one anti-abortion groups have been pushing for. It extends beyond Costco's membership, since nonmembers can fill prescriptions at its drug counters. Last August, Alliance Defending Freedom led a coalition including thousands of Costco cardholders, financial advisers and consultants in urging the retailer not to offer mifepristone. "Costco ... needs to carefully consider the cost of alienating its diverse customers and potential customers just to boost one product in its pharmacy, which is one of its ancillary lines of business," their letter said. That pressure campaign followed New York City Comptroller Brad Lander (D) sending letters to Costco and other pharmacies, advocating that they get clearance to fill prescriptions where legal. "Making mifepristone available benefits customers and employees and increases sales, while also generating long-term shareholder value," Lander wrote to Costco last year. But abortion foes have allied with investor groups like Inspire Investing to warn Costco, Walmart, Albertsons, Kroger and other retail pharmacy operators as well as drug distributors to stay out of divisive political issues that could alienate customers and investors. "We say, OK, mifepristone may be a very small part of your sales, but look at all of the different backlash that you might be introducing, the different regulatory backlash from the Trump admin and the legal risk," Ross said. The Trump administration, Congress or the Supreme Court could still change requirements around the drug. The Supreme Court in 2024 preserved access to mifepristone, deciding that doctors who asked justices to stop the FDA's relaxation of restrictions around the drug didn't have standing, without ruling on the merits. In May, HHS Secretary Robert F. Kennedy Jr. said he'd directed the FDA to "to review the latest data on mifepristone" — a move that could restrict future availability. Other large pharmacy chains like Walmart, Kroger and Albertsons have not made public decisions on mifepristone dispensing. Kroger told Axios it's still reviewing the FDA's mifepristone drug safety program and will continue to align dispensing practices with federal and state law. Walmart declined to comment, and Albertsons did not respond. The other side: Curbing mifepristone access could make it even harder for women to access safe abortions, as well as miscarriage care, for which it has an off-label use. "By refusing to offer mifepristone, Costco has chosen politics over science, fear over facts, and ideology over the rights of its customers," Mini Timmaraju, CEO of advocacy group Reproductive Freedom for All, said in a statement last Friday. What we're watching: How Walgreens and CVS respond to pressure to stop filling mifepristone prescriptions.
3 days ago
Brazil's former president Bolsonaro temporarily leaves house arrest for medical exams
SAO PAULO -- SAO PAULO (AP) — Brazil's Former President Jair Bolsonaro temporarily left house arrest Saturday to undergo medical exams in Brasilia, after a judge authorized him to spend six to eight hours at a hospital. Doctors at DF Star hospital said Bolsonaro was admitted for evaluation of fever, cough, persistent gastroesophageal reflux and hiccups. Tests revealed residual signs of two recent pulmonary infections, as well as persistent esophagitis and gastritis. He was discharged later in the day and will continue treatment with medication. He has been hospitalized multiple times since being stabbed at a campaign event before the 2018 presidential election. His most recent surgery was in April, for a bowel obstruction. Bolsonaro is on trial at the Supreme Court over his alleged attempt to remain in power after losing the 2022 election to President Luiz Inácio Lula da Silva. A five-justice panel is expected to deliver verdicts and sentences on five counts against him between Sept. 2 and 12. Bolsonaro denies any wrongdoing. The far-right leader has been under house arrest since Aug. 5. Supreme Court Justice Alexandre de Moraes, who oversees the case, said Bolsonaro violated precautionary measures by spreading content through his three lawmaker sons. A small group of fewer than 20 people gathered outside DF Star hospital Saturday, claiming Bolsonaro is a victim of political persecution. Some thanked U.S. President Donald Trump, who has called the prosecution a 'witch hunt' and linked his decision to impose a 50% tariff on Brazilian imports to Bolsonaro's legal troubles. ___ Luís Nova contributed reporting in Brasilia. ___
The Hill
3 days ago
- The Hill
Brazil's former president Bolsonaro temporarily leaves house arrest for medical exams
SAO PAULO (AP) — Brazil's Former President Jair Bolsonaro temporarily left house arrest Saturday to undergo medical exams in Brasilia, after a judge authorized him to spend six to eight hours at a hospital. Doctors at DF Star hospital said Bolsonaro was admitted for evaluation of fever, cough, persistent gastroesophageal reflux and hiccups. Tests revealed residual signs of two recent pulmonary infections, as well as persistent esophagitis and gastritis. He was discharged later in the day and will continue treatment with medication. He has been hospitalized multiple times since being stabbed at a campaign event before the 2018 presidential election. His most recent surgery was in April, for a bowel obstruction. Bolsonaro is on trial at the Supreme Court over his alleged attempt to remain in power after losing the 2022 election to President Luiz Inácio Lula da Silva. A five-justice panel is expected to deliver verdicts and sentences on five counts against him between Sept. 2 and 12. Bolsonaro denies any wrongdoing. The far-right leader has been under house arrest since Aug. 5. Supreme Court Justice Alexandre de Moraes, who oversees the case, said Bolsonaro violated precautionary measures by spreading content through his three lawmaker sons. A small group of fewer than 20 people gathered outside DF Star hospital Saturday, claiming Bolsonaro is a victim of political persecution. Some thanked U.S. President Donald Trump, who has called the prosecution a 'witch hunt' and linked his decision to impose a 50% tariff on Brazilian imports to Bolsonaro's legal troubles.
